Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to further characterize basic pharmacokinetic (PK) parameters in
healthy children to contribute to evidence for the safety of silver diamine fluoride (SDF;
Advantage Arrest). Children with at least one active cavity will be treated and then have
blood draws at random time points afterwards.